Biomaterial Strategies for Immunomodulation.

Strategies to enhance, suppress, or qualitatively shape the immune response are of importance for diverse biomedical applications, such as the development of new vaccines, treatments for autoimmune diseases and allergies, strategies for regenerative medicine, and immunotherapies for cancer. However, the intricate cellular and molecular signals regulating the immune system are major hurdles to predictably manipulating the immune response and developing safe and effective therapies. To meet this challenge, biomaterials are being developed that control how, where, and when immune cells are stimulated in vivo, and that can finely control their differentiation in vitro. We review recent advances in the field of biomaterials for immunomodulation, focusing particularly on designing biomaterials to provide controlled immunostimulation, targeting drugs and vaccines to lymphoid organs, and serving as scaffolds to organize immune cells and emulate lymphoid tissues. These ongoing efforts highlight the many ways in which biomaterials can be brought to bear to engineer the immune system.

[1]  Youngjin Choi,et al.  Injectable, spontaneously assembling inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy , 2014, Nature Biotechnology.

[2]  J. Babensee,et al.  Phenotype and polarization of autologous T cells by biomaterial-treated dendritic cells. , 2015, Journal of biomedical materials research. Part A.

[3]  Nathan A Hotaling,et al.  Presentation Modality of Glycoconjugates Modulates Dendritic Cell Phenotype. , 2014, Biomaterials science.

[4]  Nathan A Hotaling,et al.  Molecular factors in dendritic cell responses to adsorbed glycoconjugates. , 2014, Biomaterials.

[5]  R. Compans,et al.  Nanoclusters self-assembled from conformation-stabilized influenza M2e as broadly cross-protective influenza vaccines. , 2014, Nanomedicine : nanotechnology, biology, and medicine.

[6]  Krishnendu Roy,et al.  Generation of Functional, Antigen‐Specific CD8+ Human T Cells from Cord Blood Stem Cells Using Exogenous Notch and Tetramer‐TCR Signaling , 2014, Stem cells.

[7]  Duccio Cavalieri,et al.  Carbon nanotube scaffolds instruct human dendritic cells: modulating immune responses by contacts at the nanoscale. , 2013, Nano letters.

[8]  Joel H Collier,et al.  The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation. , 2013, Biomaterials.

[9]  A. Thomson,et al.  All‐trans retinoic acid and rapamycin synergize with transforming growth factor‐β1 to induce regulatory T cells but confer different migratory capacities , 2013, Journal of leukocyte biology.

[10]  D. Irvine,et al.  Generation of Effector Memory T Cell–Based Mucosal and Systemic Immunity with Pulmonary Nanoparticle Vaccination , 2013, Science Translational Medicine.

[11]  J. Collier,et al.  A Self‐Adjuvanting Supramolecular Vaccine Carrying a Folded Protein Antigen , 2013, Advanced healthcare materials.

[12]  Molly S Bray,et al.  Integrative genomic analysis of the human immune response to influenza vaccination , 2013, eLife.

[13]  Lucia Gemma Delogu,et al.  Functionalized carbon nanotubes as immunomodulator systems. , 2013, Biomaterials.

[14]  Darrell J Irvine,et al.  In vivo targeting of adoptively transferred T-cells with antibody- and cytokine-conjugated liposomes. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[15]  Yaping Li,et al.  Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking. , 2013, Small.

[16]  D. Wraith,et al.  Regulation of Adaptive Immunity; The Role of Interleukin-10 , 2013, Front. Immunol..

[17]  K. Nazmi,et al.  Multivalent glycopeptide dendrimers for the targeted delivery of antigens to dendritic cells. , 2013, Molecular immunology.

[18]  T. Fahmy,et al.  Nanogel-based delivery of mycophenolic acid ameliorates systemic lupus erythematosus in mice. , 2013, The Journal of clinical investigation.

[19]  Sebastian J Maerkl,et al.  A high-throughput nanoimmunoassay chip applied to large-scale vaccine adjuvant screening. , 2013, Integrative biology : quantitative biosciences from nano to macro.

[20]  Tarek R. Fadel,et al.  Adsorption of multimeric T cell antigens on carbon nanotubes: effect on protein structure and antigen-specific T cell stimulation. , 2013, Small.

[21]  R. Hayward,et al.  Tuning Innate Immune Activation by Surface Texturing of Polymer Microparticles: The Role of Shape in Inflammasome Activation , 2013, The Journal of Immunology.

[22]  K. Ravichandran,et al.  Clearing the dead: apoptotic cell sensing, recognition, engulfment, and digestion. , 2013, Cold Spring Harbor perspectives in biology.

[23]  Aaron J. Martin,et al.  Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis , 2012, Nature Biotechnology.

[24]  Mark Coles,et al.  Application of tissue engineering to the immune system: development of artificial lymph nodes , 2012, Front. Immun..

[25]  D. Greiner,et al.  Humanized mice for immune system investigation: progress, promise and challenges , 2012, Nature Reviews Immunology.

[26]  Aliasger K. Salem,et al.  Biodegradable Particles as Vaccine Delivery Systems: Size Matters , 2012, The AAPS Journal.

[27]  Richard A Flavell,et al.  Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy. , 2012, Nature materials.

[28]  J. Babensee,et al.  Differential functional effects of biomaterials on dendritic cell maturation. , 2012, Acta biomaterialia.

[29]  F. Chueh,et al.  Engagement of T-cell antigen receptor and CD4/CD8 co-receptors induces prolonged STAT activation through autocrine/paracrine stimulation in human primary T cells. , 2012, Biochemical and biophysical research communications.

[30]  Satish Mishra,et al.  Self-assembled peptide nanofibers raising durable antibody responses against a malaria epitope. , 2012, Biomaterials.

[31]  D. Irvine,et al.  Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles. , 2012, Biomaterials.

[32]  D. Jackson,et al.  Control of size dispersity of chitosan biopolymer microparticles and nanoparticles to influence vaccine trafficking and cell uptake. , 2012, Journal of biomedical materials research. Part A.

[33]  Francisco J. Quintana,et al.  Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis , 2012, Proceedings of the National Academy of Sciences.

[34]  David C. Smith,et al.  Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. , 2012, The New England journal of medicine.

[35]  Benjamin C. Tang,et al.  Mucus-Penetrating Nanoparticles for Vaginal Drug Delivery Protect Against Herpes Simplex Virus , 2012, Science Translational Medicine.

[36]  Koichiro Uto,et al.  Substrate stiffness modulates gene expression and phenotype in neonatal cardiomyocytes in vitro. , 2012, Tissue engineering. Part A.

[37]  R. Locksley,et al.  Spatiotemporally separated antigen uptake by alveolar dendritic cells and airway presentation to T cells in the lung , 2012, The Journal of experimental medicine.

[38]  M. Nouri-Shirazi,et al.  Macrophage chitin binding proteins in phagocytosis and M1 activation in response to chitin microparticles (172.27) , 2012, The Journal of Immunology.

[39]  K. Anseth,et al.  Strategies to reduce dendritic cell activation through functional biomaterial design. , 2012, Biomaterials.

[40]  James J Moon,et al.  Engineering Nano‐ and Microparticles to Tune Immunity , 2012, Advanced materials.

[41]  M. Bachmann,et al.  Innate Immunity Mediates Follicular Transport of Particulate but Not Soluble Protein Antigen , 2012, The Journal of Immunology.

[42]  A. Thomson,et al.  Controlled release formulations of IL-2, TGF-β1 and rapamycin for the induction of regulatory T cells. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[43]  K. Leong,et al.  Synthetic mast-cell granules as adjuvants to promote and polarize immunity in lymph nodes. , 2012, Nature materials.

[44]  J. Babensee,et al.  Predicting biomaterial property-dendritic cell phenotype relationships from the multivariate analysis of responses to polymethacrylates. , 2012, Biomaterials.

[45]  Joel H Collier,et al.  Modulating adaptive immune responses to peptide self-assemblies. , 2012, ACS nano.

[46]  D. Irvine,et al.  Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction , 2012, Proceedings of the National Academy of Sciences.

[47]  T. Eberlein Durable Complete Responses in Heavily Pretreated Patients with metastatic Melanoma Using T-Cell Transfer Immunotherapy , 2012 .

[48]  George Coukos,et al.  Cancer immunotherapy comes of age , 2011, Nature.

[49]  Ling Peng,et al.  Systemic administration of combinatorial dsiRNAs via nanoparticles efficiently suppresses HIV-1 infection in humanized mice. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[50]  K. Landfester,et al.  Criteria impacting the cellular uptake of nanoparticles: a study emphasizing polymer type and surfactant effects. , 2011, Acta biomaterialia.

[51]  S. Mitragotri,et al.  Adaptive micro and nanoparticles: temporal control over carrier properties to facilitate drug delivery. , 2011, Advanced drug delivery reviews.

[52]  Ashutosh Kumar Singh,et al.  An injectable synthetic immune-priming center mediates efficient T-cell class switching and T-helper 1 response against B cell lymphoma. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[53]  A. Traboulsee,et al.  A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS , 2011, Neurology.

[54]  R. Gold,et al.  Liposomal Encapsulation of Glucocorticoids Alters Their Mode of Action in the Treatment of Experimental Autoimmune Encephalomyelitis , 2011, The Journal of Immunology.

[55]  J. Hubbell,et al.  Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination , 2011, Proceedings of the National Academy of Sciences.

[56]  J. Hubbell,et al.  Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis. , 2011, Vaccine.

[57]  V. Rotello,et al.  Modulating Pharmacokinetics, Tumor Uptake and Biodistribution by Engineered Nanoparticles , 2011, PloS one.

[58]  D. Irvine,et al.  In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles , 2011, Proceedings of the National Academy of Sciences.

[59]  Thommey P. Thomas,et al.  Folate-targeted nanoparticles show efficacy in the treatment of inflammatory arthritis. , 2011, Arthritis and rheumatism.

[60]  Jun Jiao,et al.  Alpha-alumina nanoparticles induce efficient autophagy-dependent cross-presentation and potent antitumour response , 2011, Nature nanotechnology.

[61]  Tarek R. Fadel,et al.  An Artificial Antigen-presenting Cell with Paracrine Delivery of IL-2 Impacts the Magnitude and Direction of the T Cell Response* , 2011, The Journal of Biological Chemistry.

[62]  Eva K. Lee,et al.  Systems Biology of Seasonal Influenza Vaccination in Humans , 2011, Nature Immunology.

[63]  T. Fahmy,et al.  Pathogen-associated molecular patterns on biomaterials: a paradigm for engineering new vaccines. , 2011, Trends in biotechnology.

[64]  S. Akira,et al.  Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. , 2011, Immunity.

[65]  Kit S Lam,et al.  The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles. , 2011, Biomaterials.

[66]  Ping Zhang,et al.  Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity , 2011, Nature Medicine.

[67]  Jangwook P. Jung,et al.  Multifactorial optimization of endothelial cell growth using modular synthetic extracellular matrices. , 2011, Integrative biology : quantitative biosciences from nano to macro.

[68]  J. Babensee,et al.  Dendritic cell responses to surface properties of clinical titanium surfaces. , 2011, Acta biomaterialia.

[69]  Jason Park,et al.  Modulation of CD4+ T lymphocyte lineage outcomes with targeted, nanoparticle-mediated cytokine delivery. , 2011, Molecular pharmaceutics.

[70]  J. Babensee,et al.  The role of integrins in the recognition and response of dendritic cells to biomaterials. , 2011, Biomaterials.

[71]  Wah Chiu,et al.  Interbilayer-Crosslinked Multilamellar Vesicles as Synthetic Vaccines for Potent Humoral and Cellular Immune Responses , 2011, Nature materials.

[72]  S. Reed,et al.  Use of defined TLR ligands as adjuvants within human vaccines , 2011, Immunological reviews.

[73]  L. Kaminskas,et al.  Nanosized Drug Delivery Vectors and the Reticuloendothelial System , 2011 .

[74]  D. Mooney,et al.  Immunologically active biomaterials for cancer therapy. , 2011, Current topics in microbiology and immunology.

[75]  Robert Langer,et al.  Polymer surface functionalities that control human embryoid body cell adhesion revealed by high throughput surface characterization of combinatorial material microarrays. , 2010, Biomaterials.

[76]  J. Tschopp,et al.  Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1α and IL-1β , 2010, Proceedings of the National Academy of Sciences.

[77]  W. Saltzman,et al.  Vaccine delivery by polymeric vehicles in the mouse reproductive tract induces sustained local and systemic immunity. , 2010, Molecular pharmaceutics.

[78]  An Lebacq,et al.  Gene Expression Study of Monocytes/Macrophages during Early Foreign Body Reaction and Identification of Potential Precursors of Myofibroblasts , 2010, PloS one.

[79]  J. Babensee,et al.  Biomaterial adjuvant effect is attenuated by anti-inflammatory drug delivery or material selection. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[80]  E. Fikrig,et al.  TLR9-Targeted Biodegradable Nanoparticles as Immunization Vectors Protect against West Nile Encephalitis , 2010, The Journal of Immunology.

[81]  D. Schadendorf,et al.  Improved survival with ipilimumab in patients with metastatic melanoma. , 2010, The New England journal of medicine.

[82]  C. Coban,et al.  The role of multiple toll-like receptor signalling cascades on interactions between biomedical polymers and dendritic cells. , 2010, Biomaterials.

[83]  Bali Pulendran,et al.  Programming dendritic cells to induce TH2 and tolerogenic responses , 2010, Nature Immunology.

[84]  Joseph M. DeSimone,et al.  Strategies in the design of nanoparticles for therapeutic applications , 2010, Nature Reviews Drug Discovery.

[85]  J. Babensee,et al.  Validation of a high-throughput methodology to assess the effects of biomaterials on dendritic cell phenotype. , 2010, Acta biomaterialia.

[86]  Uwe Marx,et al.  Immunological substance testing on human lymphatic micro-organoids in vitro. , 2010, Journal of biotechnology.

[87]  Samir Mitragotri,et al.  Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects. , 2010, Current pharmaceutical design.

[88]  Soong Ho Um,et al.  Therapeutic cell engineering using surface-conjugated synthetic nanoparticles , 2010, Nature Medicine.

[89]  Cui Tang,et al.  Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. , 2010, Biomaterials.

[90]  Pau Serra,et al.  Reversal of autoimmunity by boosting memory-like autoregulatory T cells. , 2010, Immunity.

[91]  S. Yoo,et al.  Highly ordered hexagonal arrays of hybridized micelles from bimodal self-assemblies of diblock copolymer micelles. , 2010, Macromolecular rapid communications.

[92]  E. Topp,et al.  Immune response to controlled release of immunomodulating peptides in a murine experimental autoimmune encephalomyelitis (EAE) model. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[93]  S. Mitragotri,et al.  Endocytosis and Intracellular Distribution of PLGA Particles in Endothelial Cells: Effect of Particle Geometry. , 2010, Macromolecular rapid communications.

[94]  Takeshi Watanabe,et al.  Artificial engineering of secondary lymphoid organs. , 2010, Advances in immunology.

[95]  D. Mueller Mechanisms maintaining peripheral tolerance , 2010, Nature Immunology.

[96]  Jangwook P. Jung,et al.  A self-assembling peptide acting as an immune adjuvant , 2009, Proceedings of the National Academy of Sciences.

[97]  Samuel K. Lai,et al.  Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses , 2009, Proceedings of the National Academy of Sciences.

[98]  D. Irvine,et al.  Engulfing tumors with synthetic extracellular matrices for cancer immunotherapy. , 2009, Biomaterials.

[99]  David J Mooney,et al.  In Situ Regulation of DC Subsets and T Cells Mediates Tumor Regression in Mice , 2009, Science Translational Medicine.

[100]  T. Fahmy,et al.  Biomimetic approaches to modulating the T cell immune response with nano- and micro- particles , 2009, 2009 Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[101]  Ashutosh Kumar Singh,et al.  In-situ crosslinking hydrogels for combinatorial delivery of chemokines and siRNA-DNA carrying microparticles to dendritic cells. , 2009, Biomaterials.

[102]  Melody A. Swartz,et al.  Fluid Flow Regulates Stromal Cell Organization and CCL21 Expression in a Tissue-Engineered Lymph Node Microenvironment1 , 2009, The Journal of Immunology.

[103]  S. Riddell,et al.  Safety and immunologic effects of IL-15 administration in nonhuman primates. , 2009, Blood.

[104]  R. Parkhill,et al.  An Immunologic Model for Rapid Vaccine Assessment — A Clinical Trial in a Test Tube , 2009, Alternatives to laboratory animals : ATLA.

[105]  Yuan Yuan,et al.  Long-circulation of hemoglobin-loaded polymeric nanoparticles as oxygen carriers with modulated surface charges. , 2009, International journal of pharmaceutics.

[106]  T. Xia,et al.  Understanding biophysicochemical interactions at the nano-bio interface. , 2009, Nature materials.

[107]  Richard A Flavell,et al.  Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy. , 2009, Vaccine.

[108]  Yuan Yuan,et al.  Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan. , 2009, Biomaterials.

[109]  U. Aebi,et al.  Peptide nanoparticles serve as a powerful platform for the immunogenic display of poorly antigenic actin determinants. , 2009, Journal of molecular biology.

[110]  Kenny K. Tran,et al.  The role of phagosomal pH on the size-dependent efficiency of cross-presentation by dendritic cells. , 2009, Biomaterials.

[111]  J. Collins,et al.  Anionic PAMAM dendrimers as drug delivery vehicles for transition metal-based anticancer drugs. , 2009, Journal of inorganic biochemistry.

[112]  J. Hanes,et al.  Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. , 2009, Advanced drug delivery reviews.

[113]  H. Hammad,et al.  Mechanism of action of clinically approved adjuvants. , 2009, Current opinion in immunology.

[114]  David J. Mooney,et al.  Infection-Mimicking Materials to Program Dendritic Cells In Situ , 2008, Nature materials.

[115]  D. Irvine,et al.  Modular injectable matrices based on alginate solution/microsphere mixtures that gel in situ and co-deliver immunomodulatory factors. , 2008, Acta biomaterialia.

[116]  Benjamin G Keselowsky,et al.  Adhesive substrate-modulation of adaptive immune responses. , 2008, Biomaterials.

[117]  Ashutosh Kumar Singh,et al.  Efficient modulation of T-cell response by dual-mode, single-carrier delivery of cytokine-targeted siRNA and DNA vaccine to antigen-presenting cells. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[118]  Aaron J. Martin,et al.  ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanisms , 2008, Proceedings of the National Academy of Sciences.

[119]  D. Irvine,et al.  Injectable dendritic cell-carrying alginate gels for immunization and immunotherapy. , 2008, Biomaterials.

[120]  Mark E. Davis,et al.  Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.

[121]  Ke-Xin Zhang,et al.  Shape effects of nanoparticles conjugated with cell-penetrating peptides (HIV Tat PTD) on CHO cell uptake. , 2008, Bioconjugate chemistry.

[122]  K. Rock,et al.  Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization , 2008, Nature Immunology.

[123]  Samir Mitragotri,et al.  Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[124]  Eric Pridgen,et al.  Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles , 2008, Molecular pharmaceutics.

[125]  Jianhong Cao,et al.  Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1. , 2008, The New England journal of medicine.

[126]  Tarek R. Fadel,et al.  Enhanced cellular activation with single walled carbon nanotube bundles presenting antibody stimuli. , 2008, Nano letters.

[127]  D. Irvine,et al.  Inverse opal hydrogel-collagen composite scaffolds as a supportive microenvironment for immune cell migration. , 2008, Journal of biomedical materials research. Part A.

[128]  Katrin Schwarz,et al.  Nanoparticles target distinct dendritic cell populations according to their size , 2008, European journal of immunology.

[129]  J. Babensee Interaction of dendritic cells with biomaterials. , 2008, Seminars in immunology.

[130]  D. Irvine,et al.  Lymphoid tissue engineering: invoking lymphoid tissue neogenesis in immunotherapy and models of immunity. , 2008, Seminars in immunology.

[131]  Samir Mitragotri,et al.  Role of Particle Size in Phagocytosis of Polymeric Microspheres , 2008, Pharmaceutical Research.

[132]  M. Sixt,et al.  The microanatomy of T‐cell responses , 2008, Immunological reviews.

[133]  K. Sheng,et al.  Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo , 2008, European journal of immunology.

[134]  T. Koga,et al.  Self-Assembled Peptide Nanofibers , 2008 .

[135]  S. Mackinnon,et al.  Adoptive cellular therapy for cytomegalovirus infection following allogeneic stem cell transplantation using virus-specific T cells. , 2008, Blood cells, molecules & diseases.

[136]  Mauro Ferrari,et al.  Intravascular Delivery of Particulate Systems: Does Geometry Really Matter? , 2008, Pharmaceutical Research.

[137]  Samir Mitragotri,et al.  Shape Induced Inhibition of Phagocytosis of Polymer Particles , 2008, Pharmaceutical Research.

[138]  Michael Sixt,et al.  Lymph node chemokines promote sustained T lymphocyte motility without triggering stable integrin adhesiveness in the absence of shear forces , 2007, Nature Immunology.

[139]  Sai T Reddy,et al.  Exploiting lymphatic transport and complement activation in nanoparticle vaccines , 2007, Nature Biotechnology.

[140]  Samir Mitragotri,et al.  Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[141]  M. Jenkins,et al.  The humoral immune response is initiated in lymph nodes by B cells that acquire soluble antigen directly in the follicles. , 2007, Immunity.

[142]  Jason K. Pontrello,et al.  Activating B cell signaling with defined multivalent ligands. , 2007, ACS chemical biology.

[143]  Noriaki Okamoto,et al.  Artificial lymph nodes induce potent secondary immune responses in naive and immunodeficient mice. , 2007, The Journal of clinical investigation.

[144]  T. Fahmy,et al.  A nanoscopic multivalent antigen-presenting carrier for sensitive detection and drug delivery to T cells. , 2007, Nanomedicine : nanotechnology, biology, and medicine.

[145]  W. Roos,et al.  Cell-assisted assembly of colloidal crystallites. , 2007, Soft matter.

[146]  Krishnendu Roy,et al.  Biomaterial-based notch signaling for the differentiation of hematopoietic stem cells into T cells. , 2006, Journal of biomedical materials research. Part A.

[147]  Sai T Reddy,et al.  Targeting dendritic cells with biomaterials: developing the next generation of vaccines. , 2006, Trends in immunology.

[148]  S. Rosenberg,et al.  Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes , 2006, Science.

[149]  Uwe Marx,et al.  A human lymph node in vitro--challenges and progress. , 2006, Artificial organs.

[150]  A. Zahr,et al.  Macrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol). , 2006, Langmuir : the ACS journal of surfaces and colloids.

[151]  Jean-Pierre Benoit,et al.  Parameters influencing the stealthiness of colloidal drug delivery systems. , 2006, Biomaterials.

[152]  Sai T Reddy,et al.  In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[153]  S. Liao,et al.  Lymphoid organ development: from ontogeny to neogenesis , 2006, Nature Immunology.

[154]  P. Kozlowski,et al.  Mucosal vaccines: the promise and the challenge , 2006, Nature Reviews Immunology.

[155]  Nicholas A Peppas,et al.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.

[156]  K. Landfester,et al.  Preparation of Fluorescent Carboxyl and Amino Functionalized Polystyrene Particles by Miniemulsion Polymerization as Markers for Cells , 2005 .

[157]  C. Coban,et al.  Manifold Mechanisms of Toll-Like Receptor-Ligand Recognition , 2005, Journal of Clinical Immunology.

[158]  J. Babensee,et al.  Differential levels of dendritic cell maturation on different biomaterials used in combination products. , 2005, Journal of biomedical materials research. Part A.

[159]  Sven Frokjaer,et al.  Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. , 2005, International journal of pharmaceutics.

[160]  J. Strominger,et al.  Differential induction of IgE-mediated anaphylaxis after soluble vs. cell-bound tolerogenic peptide therapy of autoimmune encephalomyelitis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[161]  J. Babensee,et al.  The effect of the physical form of poly(lactic-co-glycolic acid) carriers on the humoral immune response to co-delivered antigen. , 2005, Biomaterials.

[162]  Harry E Rubash,et al.  Gene expression clustering using self-organizing maps: analysis of the macrophage response to particulate biomaterials. , 2005, Biomaterials.

[163]  Jan Holmgren,et al.  Mucosal immunity and vaccines , 2005, Nature Medicine.

[164]  Bengt Rippe,et al.  Ficoll and dextran vs. globular proteins as probes for testing glomerular permselectivity: effects of molecular size, shape, charge, and deformability. , 2005, American journal of physiology. Renal physiology.

[165]  Daniel Coombs,et al.  T cell receptor binding kinetics required for T cell activation depend on the density of cognate ligand on the antigen-presenting cell. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[166]  S. Metcalfe,et al.  Leukemia Inhibitory Factor Is Linked to Regulatory Transplantation Tolerance , 2005, Transplantation.

[167]  Anna Bershteyn,et al.  Bioactive Hydrogels with an Ordered Cellular Structure Combine Interconnected Macroporosity and Robust Mechanical Properties , 2005 .

[168]  M. Ferrari,et al.  A Theoretical Model for the Margination of Particles within Blood Vessels , 2005, Annals of Biomedical Engineering.

[169]  Jeffrey A Hubbell,et al.  Oxidation-sensitive polymeric nanoparticles. , 2005, Langmuir : the ACS journal of surfaces and colloids.

[170]  S. Shaw,et al.  Conduit for privileged communications in the lymph node. , 2005, Immunity.

[171]  J. Cyster,et al.  Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. , 2005, Annual review of immunology.

[172]  Takeshi Watanabe,et al.  Generation of a synthetic lymphoid tissue–like organoid in mice , 2004, Nature Biotechnology.

[173]  W. Hancock,et al.  Approach to the comprehensive analysis of glycoproteins isolated from human serum using a multi-lectin affinity column. , 2004, Journal of chromatography. A.

[174]  Jie Li,et al.  Size-Dependent Immunogenicity: Therapeutic and Protective Properties of Nano-Vaccines against Tumors1 , 2004, The Journal of Immunology.

[175]  S. Rosenberg,et al.  Cancer immunotherapy: moving beyond current vaccines , 2004, Nature Medicine.

[176]  J. Babensee,et al.  Humoral immune responses to model antigen co-delivered with biomaterials used in tissue engineering. , 2004, Biomaterials.

[177]  R. Mebius Organogenesis of lymphoid tissues , 2003, Nature reviews. Immunology.

[178]  M. Alonso,et al.  Biodegradable micro- and nanoparticles as long-term delivery vehicles for interferon-alpha. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[179]  Allison L. Sieving,et al.  Morphological characteristics of total joint arthroplasty-derived ultra-high molecular weight polyethylene (UHMWPE) wear debris that provoke inflammation in a murine model of inflammation. , 2003, Journal of biomedical materials research. Part A.

[180]  M. Raffeld,et al.  Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes , 2002, Science.

[181]  C. Geisler,et al.  A Response Calculus for Immobilized T Cell Receptor Ligands* , 2001, The Journal of Biological Chemistry.

[182]  H. Merkle,et al.  Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages? , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[183]  S M Moghimi,et al.  Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.

[184]  Jian Ding,et al.  PEGylated polycyanoacrylate nanoparticles as tumor necrosis factor-α carriers , 2001 .

[185]  Younan Xia,et al.  Self‐Assembly of Monodispersed Spherical Colloids into Complex Aggregates with Well‐Defined Sizes, Shapes, and Structures , 2001 .

[186]  J. Frank,et al.  Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand , 2000, Nature Medicine.

[187]  T. Meyer,et al.  Efficient generation of human T cells from a tissue-engineered thymic organoid , 2000, Nature Biotechnology.

[188]  A. Mikos,et al.  Controlled release of transforming growth factor β1 from biodegradable polymer microparticles , 2000 .

[189]  D. Fischer,et al.  Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[190]  F. Yuan,et al.  Transvascular drug delivery in solid tumors. , 1998, Seminars in radiation oncology.

[191]  Smadar Cohen,et al.  Characterization of PLGA microspheres for the controlled delivery of IL-1α for tumor immunotherapy , 1997 .

[192]  Gert Storm,et al.  Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system , 1995 .

[193]  R. Müller,et al.  The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. , 1995, Advanced drug delivery reviews.

[194]  V. Torchilin,et al.  Biodegradable long-circulating polymeric nanospheres. , 1994, Science.

[195]  E. Jaffee,et al.  Controlled release, biodegradable cytokine depots: a new approach in cancer vaccine design. , 1993, Cancer research.

[196]  R. K. Rana,et al.  Controlled Release of Interleukin-2 from Biodegradable Microspheres , 1990, Bio/Technology.

[197]  J. Thompson,et al.  Recombinant interleukin 2 toxicity, pharmacokinetics, and immunomodulatory effects in a phase I trial. , 1987, Cancer research.

[198]  Clive G. Wilson,et al.  Blood clearance and organ deposition of intravenously administered colloidal particles. The effects of particle size, nature and shape , 1982 .

[199]  R L Juliano,et al.  The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs. , 1975, Biochemical and biophysical research communications.

[200]  H. Baumgartner,et al.  The role of blood flow in platelet adhesion, fibrin deposition, and formation of mural thrombi. , 1973, Microvascular research.